Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy.

CONCLUSIONS: Spatiotemporal fractionation may reduce the risk of liver toxicity or facilitate dose escalation in liver SBRT in circumstances where the mean dose to the non-involved liver is the prescription-limiting factor.
PMID: 28951010 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - September 23, 2017 Category: Radiology Authors: Unkelbach J, Papp D, Gaddy MR, Andratschke N, Hong T, Guckenberger M Tags: Radiother Oncol Source Type: research